Adjunct ultrasonography for breast cancer screening in women at average risk: A systematic review

International Journal of Evidence-Based Healthcare

Volumn 11, Issue 2, 2013, Pages 87-93

  Gartlehner, Gerald ^a,c   Thaler, Kylie J ^a   Chapman, Andrea ^a   Kaminski, Angela ^a   Berzaczy, Dominik ^b   Van Noord, Megan G ^a   Helbich, Thomas H ^b  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c RTI INTERNATIONAL   (United States)

Author keywords

Breast cancer; Mammography; Mass screening; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; ECHOGRAPHY; ECHOMAMMOGRAPHY; ECONOMICS; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAMMOGRAPHY; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARD; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 84878995730     PISSN: 17441595     EISSN: 17441609     Source Type: Journal    
DOI: 10.1111/1744-1609.12022     Document Type: Article

References (36)

1. World Health Organization. The global burden of disease: 2004 update. 2008. Accessed 30 May 2011. Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-781.
3. World Health Organization. Cancer, Key Facts. Geneva: World Health Organization, 2013. Accessed 5 April 2013. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/index.html
4. Howlader N, Noone AM, SEER KM. Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute, 2012.
5. Houssami N, Cuzick J, Dixon JM. The prevention, detection, and management of breast cancer. Med J Aust 2006; 184: 230-234.
6. United States Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151: 716-726. W-236.
7. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011; (1): CD001877.
8. Griffin JL, Pearlman MD. Breast cancer screening in women at average risk and high risk. Obstet Gynecol 2010; 116: 1410-1421.
9. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. J Am Med Assoc 2005; 293: 1245-1256.
10. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007; 146: 502-510.
11. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 727-737, W237-42.
12. Albert US, Altland H, Duda V etal. 2008 update of the guideline: early detection of breast cancer in Germany. J Cancer Res Clin Oncol 2009; 135: 339-354.
13. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition - summary document. Ann Oncol 2008; 19: 614-622.
14. Michaelson JS, Silverstein M, Sgroi D etal. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 2003; 98: 2133-2143.
15. Michaelson JS, Silverstein M, Wyatt J etal. Predicting the survival of patients with breast carcinoma using tumor size. Cancer 2002; 95: 713-723.
16. Berg WA, Blume JD, Cormack JB etal. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008; 299: 2151-2163.
17. Berg WA, Zhang Z, Lehrer D etal. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012; 307: 1394-1404.
18. Gartlehner G, Thaler K, Chapman A etal. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database Syst Rev 2013; (4): CD009632.
19. Whiting PF, Rutjes AW, Westwood ME etal. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-536.
20. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011.
21. Ohuchi N, Ishida T, Kawai M, Narikawa Y, Yamamoto S, Sobue T. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Jpn J Clin Oncol 2011; 41: 275-277.
22. Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 2000; 21: 325-336.
23. Soderstrom L, Woods WG, Bernstein M, Robison LL, Tuchman M, Lemieux B. Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening. J Natl Cancer Inst 2005; 97: 1118-1124.
24. Corsetti V, Houssami N, Ghirardi M etal. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1year follow-up. Eur J Cancer 2011; 47: 1021-1026.
25. delCarmen MG, Halpern EF, Kopans DB etal. Mammographic breast density and race. AJR Am J Roentgenol 2007; 188: 1147-1150.
26. Pisano ED, Gatsonis C, Hendrick E etal. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005; 353: 1773-1783.
27. Carney PA, Miglioretti DL, Yankaskas BC etal. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138: 168-175.
28. Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 2005; 94: 115-122.
29. Boyd NF, Guo H, Martin LJ etal. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227-236.
30. Brancato B, Bonardi R, Catarzi S etal. Negligible advantages and excess costs of routine addition of breast ultrasonography to mammography in dense breasts. Tumori 2007; 93: 562-566.
31. Corsetti V, Ferrari A, Ghirardi M etal. Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med. 2006; 111: 440-448.
32. Corsetti V, Houssami N, Ferrari A etal. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer 2008; 44: 539-544.
33. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 2001; 221: 641-649.
34. De Felice C, Savelli S, Angeletti M etal. Diagnostic utility of combined ultrasonography and mammography in the evaluation of women with mammographically dense breasts. J Ultrasound 2007; 10: 143-151.
35. Wilson JMG, Jungner YG. Principles and Practice of Mass Screening for Disease. Geneva: World Health Organization, 1968; 19681208 DCOM- 19681208.
36. Ganott MA, Sumkin JH, King JL etal. Screening mammography: do women prefer a higher recall rate given the possibility of earlier detection of cancer? Radiology 2006; 238: 793-800.